Protagonist Therapeutics, Inc.
PTGX
$46.28
$0.481.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.63% | 46.13% | 79.96% | 39.81% | 43.93% |
| Total Receivables | 1,530.76% | 4,006.15% | 2,640.00% | 588,925.49% | 19,769.23% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.81% | 32.32% | 59.26% | -8.34% | -36.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.39% | 46.75% | 80.14% | 166.21% | 46.28% |
|
|
|||||
| Total Current Assets | 66.39% | 46.75% | 80.14% | 166.21% | 46.28% |
| Net Property, Plant & Equipment | 486.64% | 320.62% | 264.61% | -61.56% | -53.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 108.05% | 82.98% | 91.79% | 162.35% | 44.38% |
|
|
|||||
| Total Accounts Payable | 109.20% | 143.53% | -20.64% | -12.78% | -78.79% |
| Total Accrued Expenses | 22.64% | -16.40% | -21.56% | 1.19% | -21.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -55.30% | -97.50% | -- | -82.22% | -54.63% |
| Total Finance Division Other Current Liabilities | 21,129.41% | 14,093.20% | 12,977.71% | 5,375.84% | -78.93% |
| Total Other Current Liabilities | 21,129.41% | 14,093.20% | 12,977.71% | 5,375.84% | -78.93% |
| Total Current Liabilities | 122.80% | 59.97% | 57.50% | 71.81% | -31.77% |
|
|
|||||
| Total Current Liabilities | 122.80% | 59.97% | 57.50% | 71.81% | -31.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 226.36% | 158.16% | 177.69% | 190.54% | -34.18% |
|
|
|||||
| Common Stock & APIC | 6.66% | 6.07% | 8.56% | 23.17% | 26.54% |
| Retained Earnings | 44.69% | 26.57% | 27.91% | 28.42% | -14.71% |
| Treasury Stock & Other | 21.90% | 885.88% | -25.76% | -87.70% | 70.75% |
| Total Common Equity | 100.58% | 76.04% | 84.08% | 159.26% | 56.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 100.58% | 76.04% | 84.08% | 159.26% | 56.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 100.58% | 76.04% | 84.08% | 159.26% | 56.15% |
|
|
|||||